A prospective randomized multicenter phase I/II clinical trial to evaluate safety and efficacy of NOVOCART disk plus autologous disk chondrocyte transplantation in the treatment of nucleotomized and degenerative lumbar disks to avoid secondary disease: safety results of Phase I—a short report

NOVOCART(®) Disk plus, an autologous cell compound for autologous disk chondrocyte transplantation, was developed to reduce the degenerative sequel after lumbar disk surgery or to prophylactically avoid degeneration in adjacent disks, if present. The NDisc trial is an ongoing multi-center, randomize...

Descripción completa

Detalles Bibliográficos
Autores principales: Tschugg, Anja, Diepers, Michael, Simone, Steinert, Michnacs, Felix, Quirbach, Sebastian, Strowitzki, Martin, Meisel, Hans Jörg, Thomé, Claudius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566491/
https://www.ncbi.nlm.nih.gov/pubmed/27567635
http://dx.doi.org/10.1007/s10143-016-0781-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566491/
https://www.ncbi.nlm.nih.gov/pubmed/27567635
http://dx.doi.org/10.1007/s10143-016-0781-0

Ejemplares similares